Marco Mor Selected Research

Iodoacetic Acid

1/2020

Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Mor Research Topics

Disease

27	Neoplasms (Cancer) 01/2023 - 11/2011
17	Pain (Aches) 02/2024 - 06/2005
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 03/2010
10	Inflammation (Inflammations) 01/2023 - 12/2009
6	Body Weight (Weight, Body) 01/2020 - 08/2006
6	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2008
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2012
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
3	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2015 - 01/2008
2	Neuroinflammatory Diseases 01/2023 - 01/2023
2	Osteoarthritis 01/2020 - 01/2015
2	Multiple Myeloma 01/2020 - 01/2016
2	Necrosis 09/2017 - 01/2003
2	Carcinogenesis 10/2013 - 06/2012
2	Hyperalgesia 09/2013 - 03/2013
2	Catalepsy 02/2013 - 01/2006
2	Sleep Wake Disorders 12/2011 - 01/2008
1	Starvation 03/2024
1	Pleural Effusion (Pleural Effusions) 01/2024
1	Infections 09/2023
1	COVID-19 09/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Chronic Pain 10/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Anhedonia 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Uveal melanoma 09/2019
1	Monosomy 09/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Glaucoma 01/2018

Drug/Important Bio-Agent (IBA)

8	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2023 - 09/2005
7	Tyrosine Kinase InhibitorsIBA 03/2024 - 02/2008
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2024 - 03/2013
6	AcidsIBA 02/2024 - 12/2009
6	EnzymesIBA 01/2023 - 11/2011
6	EndocannabinoidsIBA 01/2023 - 07/2007
5	LipidsIBA 02/2024 - 08/2006
5	amidaseIBA 02/2024 - 12/2009
5	N-acylethanolaminesIBA 02/2024 - 12/2009
5	anandamide (arachidonylethanolamide)IBA 01/2023 - 01/2006
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021 - 08/2015
5	Gefitinib (Iressa)FDA Link 01/2019 - 07/2010
5	ErbB Receptors (EGF Receptor)IBA 03/2015 - 07/2010
4	Melatonin Receptors (Melatonin Receptor)IBA 01/2023 - 01/2008
4	EphrinsIBA 01/2023 - 06/2012
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 08/2015
4	heparanaseIBA 12/2020 - 01/2016
4	LigandsIBA 01/2016 - 06/2012
3	osimertinibIBA 03/2024 - 12/2021
3	EphA2 ReceptorIBA 01/2023 - 06/2012
3	palmidrolIBA 01/2023 - 12/2009
3	CannabinoidsIBA 01/2020 - 01/2006
3	SolutionsIBA 01/2019 - 09/2009
3	ramelteon (Rozerem)FDA Link 07/2015 - 01/2008
3	Analgesics (Analgesic Drugs)IBA 11/2011 - 07/2007
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 09/2009 - 07/2007
2	HydrolasesIBA 02/2024 - 05/2016
2	AntioxidantsIBA 01/2020 - 09/2017
2	URB937IBA 12/2019 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2015
2	Lithocholic AcidIBA 01/2016 - 04/2013
2	CarbamatesIBA 01/2016 - 09/2009
2	Sucrose (Saccharose)IBA 11/2015 - 11/2007
2	oleoylethanolamideIBA 08/2015 - 08/2006
2	Adenosine Triphosphate (ATP)IBA 03/2015 - 03/2010
2	cholanic acidIBA 10/2013 - 06/2012
2	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 09/2013 - 03/2013
2	Phosphotransferases (Kinase)IBA 01/2013 - 11/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2012 - 07/2010
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2011 - 10/2010
2	PPAR alphaIBA 12/2009 - 08/2006
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	Pyruvic Acid (Pyruvate)IBA 03/2024
1	Glutamic Acid (Glutamate)FDA Link 03/2024
1	Glutamine (L-Glutamine)FDA Link 03/2024
1	Phenylalanine (L-Phenylalanine)FDA Link 09/2023
1	Lysine (L-Lysine)FDA Link 09/2023
1	Neuroprotective AgentsIBA 01/2023
1	cilofexorIBA 01/2023
1	N-oleoylethanolamineIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 02/2022
1	Therapeutic UsesIBA 12/2021
1	CatalaseIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	CorticosteroneIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	CytokinesIBA 01/2020
1	Iodoacetic AcidIBA 01/2020
1	erdafitinibIBA 12/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	chloroacetamideIBA 01/2019
1	Proline (L-Proline)FDA Link 01/2018
1	Thymidylate SynthaseIBA 01/2018

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2010
2	Oral Administration 12/2019 - 07/2007
2	Topical Administration 09/2013 - 03/2013